Tian Zhang: Insightful look at ctDNA in colorectal cancer by Aparna Parikh

Tian Zhang, Associate Director of Clinical Research at Simmons Comprehensive Cancer Center, shared a post on X:

“Dr. Aparna Parikh, Mass General Cancer Center with insightful look at ctDNA in colorectal cancer — ctDNA and with min residual dz can find patients with stage 2 dz likely to recur and benefit from adjuvant chemotherapy.

Important lessons for us to learn for GU cancers — Alliance for Clinical Trials in Oncology’s MODERN trial ongoing!”

More posts featuring Tian Zhang and Aparna Parikh.

Tian Zhang, an Associate Director of Clinical Research at Simmons Comprehensive Cancer Center and an Associate Professor at UT Southwestern Medical Center, specializes in diagnosing and treating genitourinary cancers, including kidney, prostate, bladder, and testicular cancers. She focuses on clinical trials and translational research to develop new therapies and evaluate biomarkers for these malignancies. Dr. Zhang is a member of ASCO, AACR, and ESMO.

Aparna Raj Parikh is an Associate Professor of Medicine at Harvard Medical School and a Gastrointestinal Oncologist at Massachusetts General Hospital, where she has been practicing since September 2016. She is affiliated with the Tucker Gosnell Center for Gastrointestinal Cancers and the Henri and Belinda Termeer Center for Targeted Therapies.

Dr. Parikh’s clinical interests include clinical trials, clinical research, gastrointestinal cancer, global health, immunotherapy, and Phase I clinical trials.